Carol Giltner Gallagher's Net Worth

$4.34 Million

Who is Carol Giltner Gallagher?

Carol Giltner Gallagher has an estimated net worth of $4.34 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., Atara Biotherapeutics, Inc., ANAPTYSBIO INC, Certara, Inc., Frazier Lifesciences Acquisition Corp, Metacrine, Inc., Millendo Therapeutics, Inc., Annexon, Inc., Mirati Therapeutics, Inc., PMV Pharmaceuticals, Inc., ANADYS PHARMACEUTICALS INC, and CANCERVAX CORP.

SEC CIK

Carol Giltner Gallagher's CIK is 0001329959

Past Insider Trading and Trends

2017 was Carol Giltner Gallagher's most active year for acquiring shares with 14 total transactions. Carol Giltner Gallagher's most active month to acquire stocks was the month of May. 2015 was Carol Giltner Gallagher's most active year for disposing of shares, totalling 18 transactions. Carol Giltner Gallagher's most active month to dispose stocks was the month of July. 2014 saw Carol Giltner Gallagher paying a total of $199,991.00 for 134,379 shares, this is the most they've acquired in one year. In 2018 Carol Giltner Gallagher cashed out on 28,240 shares for a total of $957,114.00, their largest year based on trade value.